Our Programs

Created from scratch by us.

All of our programs are created by starting with a problem and identifying innovative approaches to addressing it. We are focused on the cutting edge of new science and innovation, and aim to be several years ahead of prevailing trends. View our Pipeline

Gelesis

Gelesis is focused on the development of novel therapies to induce weight loss and improve glycemic control in people who are overweight or have obesity, including those with prediabetes and type 2 diabetes. Gelesis100, one of the company’s product candidates and a first-in-class therapeutic, is currently being evaluated in a six-month pivotal study. Gelesis is also developing Gelesis200, created from the same proprietary technology platform as Gelesis100, as a product optimized to induce weight loss and improve glycemic control in patients with type 2 diabetes.

A new approach for managing obesity, diabetes and prediabetes

UPDATED APRIL 28, 2016